Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$607.51 USD

607.51
2,465,178

+58.20 (10.60%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $604.00 -3.51 (-0.58%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 22% (54 out of 251)

Industry: Medical - Dental Supplies

Zacks News

Medtronic (MDT) Gains Market Share Despite COVID Headwinds

In Respiratory Interventions, despite the year-over-year headwind, as ventilator sales continue to return to pre-pandemic levels, Medtronic (MDT) gains about 400 basis points of share.

Are These Medical Stocks Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Quidel (QDEL) Rallies 17.4% Since Posting Q4 Earnings Beat

Quidel (QDEL) stock rallies on better-than-expected fourth-quarter performance and strong diagnostics portfolio.

Here's Why You Should Invest in AmerisourceBergen (ABC) Stock

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment.

Insulet (PODD) Product Volume Up, COVID-Led Softness Persists

Insulet's (PODD) drug delivery revenues surge led by increased production volumes, driven by higher-than-expected demand from its partner.

Henry Schein (HSIC) Expands Data Analytics to Private Practices

Henry Schein's (HSIC) introduction of Jarvis Analytics for Private Practices offers practice owners a simple, powerful tool to help improve practice success through data-driven decisions.

McKesson (MCK) Up 5.1% Since Q3 Earnings: What's Driving It?

Investors are optimistic about McKesson's (MCK) robust segmental performance and raised earnings outlook for fiscal 2022.

If You Invested $1000 in McKesson 10 Years Ago, This Is How Much You'd Have Now

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

SmileDirectClub (SDC) Q4 Earnings Lag Estimates, Margin Falls

SmileDirectClub (SDC) reports lower-than-expected results for the fourth quarter, issues full-year 2022 sales guidance.

Here's Why You Should Invest In Bruker (BRKR) Stock Now

Investors are optimistic about Bruker's (BRKR) better-than-expected revenues and robust segmental performance.

Here's Why You Should Retain CVS Health (CVS) Stock for Now

Investors are optimistic about CVS Health (CVS) on continued growth in its consumer-centric digital solutions.

National Vision (EYE) Q4 Earnings Top Estimates, Margins Down

Strength in America's Best and Eyeglass World brands drove National Vision's (EYE) performance in the fourth quarter of 2021.

McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why

McKesson (MCK) could produce exceptional returns because of its solid growth attributes.

Here's Why You Should Invest In Henry Schein (HSIC) Now

Investors are optimistic about Henry Schein's (HSIC) favorable dental business trends and bullish fourth-quarter 2021 performance.

Are These Medical Stocks a Great Value Stocks Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Chemed (CHE) Q4 Earnings Surpass Estimates, Revenues Miss

Chemed (CHE) reports better-than-expected earnings for the fourth quarter, with a robust performance by the Roto-Rooter arm driving the top line.

Myriad Genetics (MYGN) Reports Loss in Q4, Gross Margin Improves

Strength in Myriad Genetics' (MYGN) Molecular Diagnostic segment has drove Q4 sales despite a challenging business environment.

Teleflex (TFX) Q4 Earnings & Revenues Top Estimates, Margins Up

Strong segmental performance in the domestic and international markets is driving Teleflex's (TFX) fourth-quarter top line.

Insulet (PODD) Q4 Earnings Surpass Estimates, Margins Up

Insulet's (PODD) fourth-quarter 2021 revenues improved year over year on a strong performance of Omnipod, both in U.S. and international markets.

NuVasive (NUVA) Q4 Earnings Miss Estimates, Gross Margin Up

Continued strong international performance and introduction of products drove NuVasive's (NUVA) revenues in the fourth quarter of 2021.

Amedisys (AMED) Q4 Earnings Top Estimates, Margins Decline

Robust performances by the Home Health and Hospice segments drove Amedisys' (AMED) fourth-quarter top line.

Exact Sciences (EXAS) Q4 Revenues Top Estimates, Margin Down

Exact Sciences' (EXAS) legacy Screening business saw strong momentum on solid Cologuard volume growth during the fourth quarter.

Tandem Diabetes (TNDM) Q4 Earnings Lag Estimates, Revenues Top

Robust domestic and international pump shipments are driving Tandem Diabetes' (TNDM) fourth-quarter top line.

Charles River (CRL) DSA Arm Sees Growth, Cell Supply Sluggish

The acquisitions of Cognate BioServices and Vigene Biosciences contribute to the growth of Charles River's (CRL) Manufacturing Solutions arm.

Henry Schein (HSIC) Up 10.1% Since Posting Q4 Earnings Beat

Henry Schein (HSIC) stock rallies on strong fourth-quarter performance and bullish 2022 EPS guidance.